Subscribe
7 April 2025NewsCareersMarisa Woutersen

PierFerd taps pharma and biotech patent expert from Weiss & Arons

Miami-based hire brings experience in patent litigation and portfolio management, having previously worked on drug cases involving Lialda, Vyvanse, and Intuniv, among others.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Careers
PierFerd adds AI patent partner with ‘dynamic experience’
17 October 2024   Former patent examiner and federal clerk brings expertise in cutting-edge technologies to the US firm.


Editor's picks

Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025

Editor's picks

Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025
Americas
Patent attorneys by day, coders by night: Sterne Kessler launches ‘homemade’ AI assistant
3 April 2025
Americas
Trouble at the USPTO—Part II: Bracing for impact
13 March 2025
Americas
‘We need the top 50 law firms to stand up’: Will Perkins Coie ignite Trump resistance?
13 March 2025
Americas
Trouble at the USPTO—Part I: Why government cutbacks are making everyone nervous
6 March 2025

More on this story

Careers
PierFerd adds AI patent partner with ‘dynamic experience’
17 October 2024   Former patent examiner and federal clerk brings expertise in cutting-edge technologies to the US firm.

More on this story

Careers
PierFerd adds AI patent partner with ‘dynamic experience’
17 October 2024   Former patent examiner and federal clerk brings expertise in cutting-edge technologies to the US firm.

More features

Fed Circ: Generic doesn’t infringe Metacel MS drug
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
Strategic IP protection for biotech-related GenAI
South Korean firm sues in UK over CRISPR/Cas9 blood disorder drug
In vivo cell therapy: A world beyond ex vivo engineering
Patent litigator with biotech and medical device background joins Sterlington
Resilience and the power of brands: Elisabeth Stewart Bradley on 9/11, inclusion and the INTA presidency